Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1330, 2002-01, pp. : 5-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Azithromycin cost advantage over standard penicillins for treating CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 353, 2002-01 ,pp. :
Access to resources
Recommend
Bupropion cost advantage over NRT
Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. :
Azithromycin preferable for CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 267, 2000-01 ,pp. :
Azithromycin + ceftriaxone as effective as levofloxacin for CAP
Inpharma, Vol. 1, Iss. 1473, 2005-01 ,pp. :
Generic captopril has cost advantage over valsartan after MI
Inpharma, Vol. 1, Iss. 1511, 2005-01 ,pp. :